On November 18, 2015, an order regarding the motion for authority to use cash collateral was filed in the bankruptcy case of Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) and its affiliates.
The filing was assigned docket number 247 and is described on the court’s official docket as follows:
Order Approving Stipulation Authorizing Use of Cash Collateral Between Debtor Response Genetics, Inc. and SWK Funding, LLC (related document(s)) Order Signed on 11/18/2015. (Attachments: # (1) Exhibit 1) (LCN)
Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on August 9, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-11663. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Pachulski Stang Ziehl & Jones LLP is acting as lead bankruptcy counsel to Response Genetics, Inc. (f/d/b/a Bio Type, Inc.) in the bankruptcy case.